Secondary failure of oral diabetes therapy
Bergis, K.; Heilmann, B.
Fortschritte der Medizin 105(4): 64-68
1987
ISSN/ISBN: 0015-8178 PMID: 3557262 Document Number: 300588
Document emailed within 1 workday
Related Documents
Bachmann, W. 1987: Therapy of diabetes mellitus in "secondary failure of sulfonylurea compounds" Medizinische Klinik 82(14): 491-494Zargar, A.H.; Masoodi, S.R.; Laway, B.A.; Wani, A.I.; Bashir, M.I. 2002: Response of regimens of insulin therapy in type 2 diabetes mellitus subjects with secondary failure Journal of the Association of Physicians of India 50(5): 641-646
González-Ortiz, M.; Martínez-Abundis, E. 2004: Efficacy and safety of glimepiride plus metformin in a single presentation, as combined therapy, in patients with type 2 diabetes mellitus and secondary failure to glibenclamide, as monotherapy Revista de Investigacion Clinica; Organo del Hospital de Enfermedades de la Nutricion 56(3): 327-333
Teuscher, A. 1972: Are oral antidiabetics ineffective-or even dangerous? The "University Group Diabetes Program" (UGDP) as basis for a controversial discussion on the therapy of diabetes in the aged Schweizerische Medizinische Wochenschrift 102(24): 848-855
Chuang, L.M.; Lu, C.; Su, R.J.; Wu, H.P.; Tai, T.Y.; Lin, B.J. 1992: Bedtime intermediate-acting insulin in the treatment of secondary failure to oral hypoglycemic agents Journal of the Formosan Medical Association 91(2): 185-189
Colman, P.G.; Harrison, L.C.; Tait, B.D. 1985: Insulin secretion and immuno-genetic markers in diabetics with 'secondary failure' of oral hypoglycemic agents Australian and New Zealand Journal of Medicine 15(2): 209-212
Durruty, P.; García de los Rios, M.; López, G. 1988: Secondary failure to oral hypoglycemic drugs: islet cell function determined by urinary C-peptide Revista Medica de Chile 116(4): 301-307
Rattarasarn, C.; Thamprasit, A.; Leelawattana, R.; Soonthornpun, S.; Setasuban, W. 2001: The role of diminished beta cell reserve and insulin resistance in secondary sulfonylurea failure of type 2 diabetes mellitus Journal of the Medical Association of Thailand 84(12): 1754-1762
Koide, K.; Sano, M.; Morio, K.; Takeda, F.; Ubukata, E.; Momose, T.; Toyama, J.; Sudo, M.; Inoue, N.; Koshikawa, S. 1987: Clinical course of beta 2-microglobulin in the plasma of patients suffering from chronic renal failure under conservative therapy in relation to oral adsorbent therapy Nihon Jinzo Gakkai Shi 29(11): 1421-1428
Takahashi, S.; Okada, K.; Kinosita, Y.; Yanai, M.; Kuno, T.; Nagura, Y. 1993: Oral 1,25(OH)2D3 pulse therapy for the treatment of secondary hyperparathyroidism Nihon Jinzo Gakkai Shi 35(4): 377-382
Girndt, J.; Scheler, F. 1979: Therapy of kidney failure in diabetes mellitus Medizinische Klinik 74(49): 1871-1875
Cauli, C.; Barcellona, D.; Marongiu, F. 2003: Oral anticoagulant therapy in the primary and secondary prophylaxis of stroke Italian Heart Journal: Official Journal of the Italian Federation of Cardiology 4(11): 755-767
Ruiz, F.; Durruty, P.; López, G.; García de los Ríos, M. 1981: Insulin levels in non-insulin dependent diabetics with secondary failure to oral hypoglycemic agents Revista Medica de Chile 109(9): 821-824
Papita, R.; Nazir, A.; Anbalagan, V.P.; Anjana, R.M.; Pitchumoni, C.; Chari, S.; Mohan, V. 2012: Secular trends of fibrocalculous pancreatic diabetes and diabetes secondary to alcoholic chronic pancreatitis at a tertiary care diabetes centre in South India Jop: Journal of the Pancreas 13(2): 205-209
Haupt, E.; Laube, F.; Loy, H.; Schöffling, K. 1977: Secondary failures in modern therapy of diabetes mellitus with blood glucose lowering sulfonamides Medizinische Klinik 72(38): 1529-1536
Teuscher, A. 1974: Treatment of diabetes in practice-analysis of the failure of dietary therapy Schweizerische Rundschau für Medizin Praxis 63(35): 1048-1052
Becker, H.; Fett, I.; Nees, E.; Peter, J.H.; von Wichert, P. 1991: Treatment of primary and secondary therapy failure in patients with sleep apnea treated with nasal CPAP Pneumologie 45(Suppl 1): 301-305
Brouzet, B.; Carratalá Perales, J.M.; Noguera Zumbühl, A.; López Uran, A.M.; Espinosa Fernández, B.; Senent Jornet, B. 2018: High-flow oxygen therapy in acute respiratory failure secondary to influenza virus infection Emergencias 30(5): 360
Bruneder, H. 1985: Possibilities and limits of oral diabetes therapy Wiener Medizinische Wochenschrift 135(6-7): 147-151
Beischer, W.; Raptis, S.; Keller, L.; Kerner, W.; Pfeiffer, E.F. 1976: C-peptide determination as a parameter for oral diabetes therapy Verhandlungen der Deutschen Gesellschaft für Innere Medizin 82 Pt 1: 791-794